CN104126719B - Preparation method for chocolate products with efficacy of radioresistance - Google Patents
Preparation method for chocolate products with efficacy of radioresistance Download PDFInfo
- Publication number
- CN104126719B CN104126719B CN201410369102.0A CN201410369102A CN104126719B CN 104126719 B CN104126719 B CN 104126719B CN 201410369102 A CN201410369102 A CN 201410369102A CN 104126719 B CN104126719 B CN 104126719B
- Authority
- CN
- China
- Prior art keywords
- parts
- chocolate
- brown sugar
- red ginseng
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000019219 chocolate Nutrition 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 57
- 239000000843 powder Substances 0.000 claims abstract description 33
- 235000000346 sugar Nutrition 0.000 claims abstract description 30
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 26
- 235000013336 milk Nutrition 0.000 claims abstract description 18
- 239000008267 milk Substances 0.000 claims abstract description 18
- 210000004080 milk Anatomy 0.000 claims abstract description 18
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 17
- 238000000605 extraction Methods 0.000 claims description 20
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 18
- 230000000694 effects Effects 0.000 claims description 17
- 244000241838 Lycium barbarum Species 0.000 claims description 16
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 16
- 235000015067 sauces Nutrition 0.000 claims description 15
- 230000003471 anti-radiation Effects 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 6
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 229940083466 soybean lecithin Drugs 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000000465 moulding Methods 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 10
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 abstract description 5
- 229930006000 Sucrose Natural products 0.000 abstract description 5
- 238000000227 grinding Methods 0.000 abstract description 5
- 238000007670 refining Methods 0.000 abstract description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 3
- 244000241872 Lycium chinense Species 0.000 abstract description 3
- 239000011575 calcium Substances 0.000 abstract description 3
- 229910052791 calcium Inorganic materials 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 230000007774 longterm Effects 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 235000019658 bitter taste Nutrition 0.000 abstract description 2
- 238000010438 heat treatment Methods 0.000 abstract description 2
- 235000019629 palatability Nutrition 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- RWXIFXNRCLMQCD-JBVRGBGGSA-N (20S)-ginsenoside Rg3 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4[C@@](C)(O)CCC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RWXIFXNRCLMQCD-JBVRGBGGSA-N 0.000 abstract 1
- XIRZPICFRDZXPF-UHFFFAOYSA-N Ginsenoside Rg3 Natural products CC(C)=CCCC(C)(O)C1CCC(C2(CC(O)C3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O XIRZPICFRDZXPF-UHFFFAOYSA-N 0.000 abstract 1
- NJUXRKMKOFXMRX-RNCAKNGISA-N Ginsenoside Rg5 Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1CC[C@]2(C)[C@H]3C[C@@H](O)[C@H]4[C@@]([C@@]3(CC[C@H]2C1(C)C)C)(C)CC[C@@H]4C(/C)=C/CC=C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NJUXRKMKOFXMRX-RNCAKNGISA-N 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- NJUXRKMKOFXMRX-AXUZFSSLSA-N ginsenoside Rg5 Natural products CC(=CCC=C(C)[C@H]1CC[C@]2(C)[C@@H]1[C@H](O)C[C@@H]3[C@@]4(C)CC[C@@H](O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)C(C)(C)[C@@H]4CC[C@@]23C)C NJUXRKMKOFXMRX-AXUZFSSLSA-N 0.000 abstract 1
- NJUXRKMKOFXMRX-UHFFFAOYSA-N ginsenoside Rz1 Natural products CC(C)=CCC=C(C)C1CCC(C2(CCC3C4(C)C)C)(C)C1C(O)CC2C3(C)CCC4OC1OC(CO)C(O)C(O)C1OC1OC(CO)C(O)C(O)C1O NJUXRKMKOFXMRX-UHFFFAOYSA-N 0.000 abstract 1
- 241000699670 Mus sp. Species 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- 230000005855 radiation Effects 0.000 description 7
- 230000004083 survival effect Effects 0.000 description 7
- 229940110456 cocoa butter Drugs 0.000 description 6
- 235000019868 cocoa butter Nutrition 0.000 description 6
- 230000037396 body weight Effects 0.000 description 5
- 210000001185 bone marrow Anatomy 0.000 description 5
- JKOQGQFVAUAYPM-UHFFFAOYSA-N amifostine Chemical compound NCCCNCCSP(O)(O)=O JKOQGQFVAUAYPM-UHFFFAOYSA-N 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 231100000636 lethal dose Toxicity 0.000 description 4
- 238000012545 processing Methods 0.000 description 4
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 240000000111 Saccharum officinarum Species 0.000 description 3
- 235000007201 Saccharum officinarum Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 230000005670 electromagnetic radiation Effects 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 229930182494 ginsenoside Natural products 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 229960001097 amifostine Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 210000000918 epididymis Anatomy 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000000265 homogenisation Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 229960004559 theobromine Drugs 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 235000019220 whole milk chocolate Nutrition 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 238000011725 BALB/c mouse Methods 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000003839 Human Proteins Human genes 0.000 description 1
- 108090000144 Human Proteins Proteins 0.000 description 1
- 231100000111 LD50 Toxicity 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000026139 Memory disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000019463 artificial additive Nutrition 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000019221 dark chocolate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000003777 experimental drug Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001965 increasing effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000006984 memory degeneration Effects 0.000 description 1
- 208000023060 memory loss Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229920001197 polyacetylene Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000000191 radiation effect Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 235000019222 white chocolate Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
技术领域:Technical field:
本发明公开一种具有抗辐射功效的巧克力制品的制备方法,属于保健食品加工技术领域。The invention discloses a method for preparing a chocolate product with anti-radiation effect, and belongs to the technical field of health food processing.
背景技术:Background technique:
巧克力是以可可做为主料的一种混合型食品。主要原料可可豆,产于赤道南北纬线18度以内狭长地带。巧克力含有丰富的镁、钾和维他命A以及可可碱,因而具有高能值。巧可力对多种动物有毒。但对人类来说,可可碱是一种健康的反镇静成分。故食用巧克力有提升精神,增强兴奋等功效。大多数人吃巧克力是为了消遣,但巧克力本身也存在一些保健功效;例如可可粉或者黑巧克力对循环系统有益处,同时也具有抗癌、刺激大脑活动、预防咳嗽和止泻等功能。通常巧克力加工工艺需要温度控制在40℃~50℃,精磨16~22小时;温度控制在48℃~65℃,精炼24~48小时,耗时、耗能,成本高。Chocolate is a mixed food with cocoa as the main ingredient. The main raw material is cocoa beans, which are produced in the narrow strip within 18 degrees north and south latitudes of the equator. Chocolate has a high energy value because it is rich in magnesium, potassium and vitamin A, as well as theobromine. Chocolate is toxic to many animals. But in humans, theobromine is a healthy anti-sedative ingredient. Therefore, eating chocolate has the effects of improving spirit and enhancing excitement. Most people eat chocolate for pleasure, but chocolate itself has some health benefits; for example, cocoa powder or dark chocolate is good for the circulatory system, and it also has functions such as fighting cancer, stimulating brain activity, preventing coughs and reducing diarrhea. Usually, the chocolate processing technology requires temperature control at 40°C-50°C, fine grinding for 16-22 hours; temperature control at 48°C-65°C, refining for 24-48 hours, which is time-consuming, energy-consuming and costly.
长期、过量的电磁辐射会对人体生殖系统、神经系统和免疫系统造成直接伤害,是心血管疾病、糖尿病、癌突变的主要诱因和造成孕妇流产、不育、畸胎等病变的诱发因素,并可直接影响未成年人的身体组织与骨骼的发育,引起视力、记忆力下降和肝脏造血功能下降,严重者可导致视网膜脱落。因此,电磁辐射已被世界卫生组织列为继水源、大气、噪声之后的第四大环境污染源,成为危害人类健康的隐形“杀手”,防护电磁辐射已成当务之急。基于以上问题,开发具有抗辐射功效的保健食品非常必要。Long-term, excessive electromagnetic radiation will cause direct damage to the human reproductive system, nervous system and immune system. It can directly affect the development of body tissues and bones of minors, causing vision, memory loss and liver hematopoietic function to decrease, and severe cases can lead to retinal detachment. Therefore, electromagnetic radiation has been listed by the World Health Organization as the fourth largest source of environmental pollution after water, air, and noise, and has become an invisible "killer" that endangers human health. Protecting electromagnetic radiation has become a top priority. Based on the above problems, it is very necessary to develop health food with anti-radiation effect.
发明内容:Invention content:
本发明提供一种具有抗辐射功效的巧克力制品,具有抗辐射等功效。The invention provides a chocolate product with anti-radiation effect, which has anti-radiation and other effects.
本发明提供一种具有抗辐射功效的巧克力制品的制备方法,以解决传统巧克力加工中耗时、耗能,成本高等问题。The invention provides a method for preparing a chocolate product with anti-radiation effect to solve the problems of time-consuming, energy-consuming and high cost in traditional chocolate processing.
本发明公开的一种具有抗辐射功效的巧克力制品,其特征在于由以下按重量份数的原料组成:A chocolate product with anti-radiation effect disclosed by the invention is characterized in that it consists of the following raw materials in parts by weight:
红参微粉:3、枸杞浸膏:1.5~5.0、红糖:15~30、乳粉:15~30、可可液块(或可可脂):45~60、大豆磷脂:0.4。Red ginseng powder: 3, wolfberry extract: 1.5-5.0, brown sugar: 15-30, milk powder: 15-30, cocoa mass (or cocoa butter): 45-60, soybean lecithin: 0.4.
本发明所述的具有抗辐射功效的巧克力制品的制备方法,包括以下步骤:The preparation method of the chocolate product with anti-radiation effect of the present invention comprises the following steps:
1)原料制备1) Raw material preparation
将红参、红糖分别在-15℃温度下粉碎至微粉;采用微波法,按照提取料液比1:10,提取时间4min,提取火力为中火,提取溶液pH值为8的条件提取枸杞;然后将提取液过滤、浓缩至1ml相当于饮片5g的浸膏;将可可液块(或可可脂):切成小块,60℃以下熔化;将红参微粉、红糖微粉、乳粉等按添加比例称重,混匀,再次上微粉粉碎机在-15℃温度下粉碎、混匀;Red ginseng and brown sugar were pulverized into fine powder at -15°C respectively; using microwave method, according to the extraction material-to-liquid ratio of 1:10, the extraction time was 4 minutes, the extraction firepower was medium fire, and the pH value of the extraction solution was 8 to extract Lycium barbarum; Then filter and concentrate the extract to 1ml of extract equivalent to 5g of decoction pieces; cut cocoa liquor (or cocoa butter) into small pieces and melt below 60°C; add red ginseng powder, brown sugar powder, milk powder, etc. Proportionally weighed, mixed evenly, and again pulverized and mixed in a micronizer at -15°C;
2)配料2) Ingredients
组方将枸杞膏和乳化剂加入熔化后的可可液块中,60℃以下保温均质10 min;Add wolfberry paste and emulsifier to the melted cocoa mass, heat and homogenize for 10 minutes below 60°C;
按组方将粉碎混匀的红参、红糖、乳粉加入熔化后的可可液块中,60℃以下保温高压均质20 min;Add the crushed and mixed red ginseng, brown sugar, and milk powder into the melted cocoa mass according to the recipe, and heat-preserve and homogenize under high pressure for 20 minutes at a temperature below 60°C;
3)成型3) Molding
巧克力酱料温度控制在28~29℃浇模;震动浇模后的巧克力酱料至无气泡;将巧克力酱料在10~15℃预冷;降温至0~5℃冷却凝固;Control the temperature of the chocolate sauce at 28-29°C and pour the mold; vibrate the molded chocolate sauce until there are no bubbles; pre-cool the chocolate sauce at 10-15°C; cool down to 0-5°C to cool and solidify;
4)脱模、包装。4) Demolding and packaging.
人参为五加科多年生草本植物人参(Panax ginseng C.A.Mey)的干燥根,近代研究证明,它具有抗衰老、抗肿瘤、增加免疫功能、降血糖、抗血脂、抗血栓和抗动脉硬化等作用。人参之所以具有多方面的药理和生物活性是因为含有多种类型有活性的化学成分,如皂苷类、多糖类、多肽类、脂肪酸、氨基酸、聚乙炔醇类等,但其主要活性成分为人参皂苷。Ginseng is the dried root of Panax ginseng CAMey, a perennial herbaceous plant of Araliaceae. Modern studies have proved that it has anti-aging, anti-tumor, increasing immune function, lowering blood sugar, anti-lipid, anti-thrombotic and anti-arteriosclerosis effects. The reason why ginseng has various pharmacological and biological activities is because it contains various types of active chemical components, such as saponins, polysaccharides, polypeptides, fatty acids, amino acids, polyacetylene alcohols, etc., but its main active components are Ginsenosides.
枸杞子具有补肝、明目的功效,因而对于视网膜、自由基和x射线辐射有着强效的保护以及消除作用。Lycium barbarum has the effects of nourishing the liver and improving eyesight, so it has a strong protection and elimination effect on the retina, free radicals and X-ray radiation.
红糖,又叫赤砂糖,是禾本科植物甘蔗的茎汁经炼制而成的赤色结晶体。研究发现,甘蔗,全身都是宝。它含有多种人体必需氨基酸,如赖氨酸等,还有苹果酸、柠檬酸等有机酸,是合成人体蛋白质、支持新陈代谢,参与人体生命活动必不可少的基础物质之一。未经过精炼的红糖保留了较多甘蔗的营养成分,也更加容易被人体消化吸收,因此能快速补充体力、增加活力,所以又被称为“东方的巧克力”,其中不仅含有可提供热能的碳水化合物,还含有人体生长发育不可缺少的核黄素、胡萝卜素、烟酸和微量元素锰、锌、铬等各种元素。此外,红糖的含钙量是白糖的10倍,含铁量是白糖的3.6倍。Brown sugar, also known as red granulated sugar, is a red crystal obtained by refining the stem juice of the grass plant sugarcane. Studies have found that sugar cane is a treasure all over the body. It contains a variety of essential amino acids, such as lysine, and organic acids such as malic acid and citric acid. It is one of the essential basic substances for synthesizing human protein, supporting metabolism, and participating in human life activities. Unrefined brown sugar retains more nutrients of sugarcane, and is easier to be digested and absorbed by the human body, so it can quickly replenish physical strength and increase vitality, so it is also called "Oriental chocolate". It not only contains carbohydrates that can provide heat energy It also contains various elements such as riboflavin, carotene, niacin and trace elements such as manganese, zinc and chromium, which are indispensable for human growth and development. In addition, the calcium content of brown sugar is 10 times that of white sugar, and the iron content is 3.6 times that of white sugar.
①利用特色红参中稀有人参皂苷Rg3(0.068~0.187)和Rg5(0.012~0.051)含量高,抗辐射活性强;枸杞进一步强化抗辐射效果;乳粉、红糖中含钙高,有助于抗辐射,以及红糖具有多种营养成分取代白砂糖,使得组方更加合理。②产品淡化了巧克力苦味,适口性好,易于携带、服用。③用超微冷冻粉碎技术和高压均质技术取代了耗时、耗能的传统精磨、精炼技术,缩短了长时间加温导致的活性成分降低等弊端,有效成分更易被吸收。④不添加人工合成添加剂,为天然食品。① Utilize the high content of rare ginsenosides Rg3 (0.068-0.187) and Rg5 (0.012-0.051) in characteristic red ginseng, which has strong anti-radiation activity; wolfberry further strengthens the anti-radiation effect; milk powder and brown sugar contain high calcium, which is helpful for anti-radiation Radiation, and brown sugar has a variety of nutrients to replace white sugar, making the formula more reasonable. ②The product dilutes the bitter taste of chocolate, has good palatability, and is easy to carry and take. ③The time-consuming and energy-consuming traditional fine grinding and refining technology is replaced by ultra-fine freezing and crushing technology and high-pressure homogenization technology, which shortens the disadvantages of reducing active ingredients caused by long-term heating, and makes active ingredients more easily absorbed. ④ No synthetic additives are added, it is a natural food.
本发明的积极效果在于:制备的红参巧克力制品选用经120℃蒸制,稀有人参皂苷Rg3和Rg5含量高的特色红参,配伍枸杞提取物强化抗辐射功效,用营养丰富的红糖代替白砂糖,并增加奶粉量进一步强化抗辐射效果;利用低温超微粉碎技术,直接将红参、红糖等原料制成超微粉体添加,取代了精磨技术;用高压均质技术替代了精炼过程。从而大大缩短了生产周期,降低了耗能,节约了成本。The positive effects of the present invention are: the prepared red ginseng chocolate products are steamed at 120°C and feature red ginseng with high content of rare ginsenosides Rg3 and Rg5, combined with Chinese wolfberry extract to strengthen the anti-radiation effect, and nutritious brown sugar is used instead of white sugar , and increase the amount of milk powder to further strengthen the anti-radiation effect; use low-temperature ultra-fine pulverization technology to directly make red ginseng, brown sugar and other raw materials into ultra-fine powder, replacing fine grinding technology; use high-pressure homogenization technology to replace the refining process. Thereby greatly shortening the production cycle, reducing energy consumption and saving costs.
具体实施方式:detailed description:
下面结合实施例对本发明做进一步的描述:The present invention will be further described below in conjunction with embodiment:
实施例1:Example 1:
称取红参微粉:3kg、枸杞浸膏:1.6kg、红糖:30kg、乳粉:20kg、可可液块:45kg、大豆磷脂:0.4;Weigh red ginseng powder: 3kg, wolfberry extract: 1.6kg, brown sugar: 30kg, milk powder: 20kg, cocoa mass: 45kg, soybean lecithin: 0.4;
所述产品的制备,包括以下步骤:The preparation of described product comprises the following steps:
1、原料制备1. Raw material preparation
(1)用贝利超微粉碎机在-15℃温度下将红参、红糖分别粉碎至微粉;(1) Grind the red ginseng and brown sugar into fine powder separately at -15°C with a Bailey ultrafine pulverizer;
(2)采用微波法,按照提取料液比1:10,提取时间4min,提取火力为中火,提取溶液pH值为8的条件提取枸杞。然后将提取液过滤、浓缩至1ml相当于饮片5g的浸膏;(2) The microwave method was used to extract wolfberry according to the extraction material-to-liquid ratio of 1:10, the extraction time was 4 minutes, the extraction firepower was medium fire, and the pH value of the extraction solution was 8. Then the extract is filtered and concentrated to 1ml of extract equivalent to 5g of decoction pieces;
(3)将可可液块:切成小块,60℃以下熔化;(3) Cocoa liquor: cut into small pieces and melt below 60°C;
(4)将红参微粉、红糖微粉、乳粉等按添加比例称重,混匀,再次上微粉粉碎机在-15℃温度下粉碎、混匀;(4) Weigh the red ginseng micropowder, brown sugar micropowder, milk powder, etc. according to the addition ratio, mix them evenly, and put them on the micropowder pulverizer again to pulverize and mix them evenly at the temperature of -15°C;
2、配料2. Ingredients
(1)按组方将枸杞膏和乳化剂加入熔化后的可可液块中,60℃以下保温均质10min;(1) According to the recipe, add wolfberry paste and emulsifier into the melted cocoa mass, keep warm and homogenize below 60°C for 10 minutes;
(2)按组方将粉碎混匀的红参、红糖、乳粉加入熔化后的可可液块中,60℃以下保温高压均质20 min;(2) Add the crushed and mixed red ginseng, brown sugar, and milk powder into the melted cocoa mass according to the recipe, and heat-preserve and homogenize under high pressure for 20 minutes at a temperature below 60°C;
3、成型3. Forming
巧克力酱料温度控制在28~29℃浇模;震动浇模后的巧克力酱料至无气泡;将巧克力酱料在10~15℃预冷;降温至0~5℃冷却凝固;Control the temperature of the chocolate sauce at 28-29°C and pour the mold; vibrate the molded chocolate sauce until there are no bubbles; pre-cool the chocolate sauce at 10-15°C; cool down to 0-5°C to cool and solidify;
4、脱模得甜型牛奶巧克力。4. Remove the mold to obtain sweet milk chocolate.
5、包装。5. Packaging.
实施例2:Example 2:
红参微粉:3kg、枸杞浸膏:1.6kg、红糖:20kg、乳粉:20kg、可可液块:55kg、大豆磷脂:0.4kg;Red ginseng powder: 3kg, wolfberry extract: 1.6kg, brown sugar: 20kg, milk powder: 20kg, cocoa mass: 55kg, soybean lecithin: 0.4kg;
所述产品的制备,包括以下步骤:The preparation of described product comprises the following steps:
1、原料制备1. Raw material preparation
(1)用贝利超微粉碎机在-15℃温度下将红参、红糖分别粉碎至微粉;(1) Grind the red ginseng and brown sugar into fine powder separately at -15°C with a Bailey ultrafine pulverizer;
(2)采用微波法,按照提取料液比1:10,提取时间4min,提取火力为中火,提取溶液pH值为8的条件提取枸杞。然后将提取液过滤、浓缩至1ml相当于饮片5g的浸膏;(2) The microwave method was used to extract wolfberry according to the extraction material-to-liquid ratio of 1:10, the extraction time was 4 minutes, the extraction firepower was medium fire, and the pH value of the extraction solution was 8. Then the extract is filtered and concentrated to 1ml of extract equivalent to 5g of decoction pieces;
(3)将可可液块:切成小块,60℃以下熔化;(3) Cocoa liquor: cut into small pieces and melt below 60°C;
(4)将红参微粉、红糖微粉、乳粉等按添加比例称重,混匀,再次上微粉粉碎机在-15℃温度下粉碎、混匀;(4) Weigh the red ginseng micropowder, brown sugar micropowder, milk powder, etc. according to the addition ratio, mix them evenly, and put them on the micropowder pulverizer again to pulverize and mix them evenly at the temperature of -15°C;
2、配料2. Ingredients
(1)按组方将枸杞膏和乳化剂加入熔化后的可可液块中,60℃以下保温均质10min。(1) According to the prescription, add wolfberry paste and emulsifier into the melted cocoa mass, keep warm and homogenize below 60°C for 10 minutes.
(2)按组方将粉碎混匀的红参、红糖、乳粉加入熔化后的可可液块中,60℃以下保温高压均质20 min;(2) Add the crushed and mixed red ginseng, brown sugar, and milk powder into the melted cocoa mass according to the recipe, and heat-preserve and homogenize under high pressure for 20 minutes at a temperature below 60°C;
3、成型3. Forming
巧克力酱料温度控制在28~29℃浇模;震动浇模后的巧克力酱料至无气泡;将巧克力酱料在10~15℃预冷;降温至0~5℃冷却凝固;Control the temperature of the chocolate sauce at 28-29°C and pour the mold; vibrate the molded chocolate sauce until there are no bubbles; pre-cool the chocolate sauce at 10-15°C; cool down to 0-5°C to cool and solidify;
4、脱模得苦型牛奶巧克力。4. Unmould to obtain bitter milk chocolate.
5、包装。5. Packaging.
实施例3:Example 3:
红参微粉:3kg、枸杞浸膏:1.6kg、红糖:20kg、乳粉:25kg、可可脂:50kg、大豆磷脂:0.4kg;Red ginseng powder: 3kg, wolfberry extract: 1.6kg, brown sugar: 20kg, milk powder: 25kg, cocoa butter: 50kg, soybean lecithin: 0.4kg;
所述产品的制备,包括以下步骤:The preparation of described product comprises the following steps:
1、原料制备1. Raw material preparation
(1)用贝利超微粉碎机在-15℃温度下将红参、红糖分别粉碎至微粉。(1) Grind the red ginseng and brown sugar into fine powders at -15°C with a Bailey ultrafine pulverizer.
(2)采用微波法,按照提取料液比1:10,提取时间4min,提取火力为中火,提取溶液pH值为8的条件提取枸杞。然后将提取液过滤、浓缩至1ml相当于饮片5g的浸膏。(2) The microwave method was used to extract wolfberry according to the extraction material-to-liquid ratio of 1:10, the extraction time was 4 minutes, the extraction firepower was medium fire, and the pH value of the extraction solution was 8. Then the extract is filtered and concentrated to 1ml of extract equivalent to 5g of decoction pieces.
(3)将可可脂:切成小块,60℃以下熔化。(3) Cocoa butter: cut into small pieces and melt below 60°C.
(4)将红参微粉、红糖微粉、乳粉等按添加比例称重,混匀,再次上微粉粉碎机在-15℃温度下粉碎、混匀。(4) Weigh the red ginseng micropowder, brown sugar micropowder, milk powder, etc. according to the addition ratio, mix them evenly, and put them on the micropowder pulverizer again to pulverize and mix them evenly at a temperature of -15°C.
2、配料2. Ingredients
(1)按组方将枸杞膏和乳化剂加入熔化后的可可脂中,60℃以下保温均质10 min。(1) Add wolfberry paste and emulsifier into the melted cocoa butter according to the recipe, keep warm and homogenize below 60°C for 10 minutes.
(2)按组方将粉碎混匀的红参、红糖、乳粉加入熔化后的可可脂中,60℃以下保温高压均质20 min。(2) Add the crushed and mixed red ginseng, brown sugar, and milk powder into the melted cocoa butter according to the recipe, and heat-preserve and homogenize under high pressure for 20 minutes below 60°C.
3、成型3. Forming
巧克力酱料温度控制在28~29℃浇模;震动浇模后的巧克力酱料至无气泡;将巧克力酱料在10~15℃预冷;降温至0~5℃冷却凝固。Control the temperature of the chocolate sauce at 28-29°C and pour the mold; vibrate the molded chocolate sauce until there are no bubbles; pre-cool the chocolate sauce at 10-15°C; cool down to 0-5°C to solidify.
4、脱模得白巧克力。4. Release the white chocolate.
5、包装。5. Packaging.
通过以下试验证明本发明产品具有抗微波辐射作用Prove that product of the present invention has anti-microwave radiation effect by following test
1、实验动物1. Experimental animals
SPF BALB/c小鼠,体重20±2g,,108只,随机分为9组,每组12只,分别为空白对照组,辐射对照组(致死剂量、半致死剂量各一组),阳性对照组(致死剂量、半致死剂量各一组),高剂量组(致死剂量、半致死剂量各一组),低剂量组(致死剂量、半致死剂量各一组)。SPF BALB/c mice, weighing 20±2g, 108, were randomly divided into 9 groups, 12 mice in each group, respectively blank control group, radiation control group (lethal dose, semi-lethal dose each group), positive control group (one group for lethal dose and half-lethal dose), high-dose group (one group for lethal dose and half-lethal dose), and low-dose group (one group for lethal dose and half-lethal dose).
2、样品2. Sample
2.1阴性对照:生理盐水2.1 Negative control: normal saline
2.2阳性药物:WR-2721氨磷汀,安多霖胶囊2.2 Positive drugs: WR-2721 Amifostine, Andolin Capsules
2.3测试药物:实施例1(A组)、实施例2(B组)、实施例3(C组);2.3 Test drugs: Example 1 (Group A), Example 2 (Group B), Example 3 (Group C);
3、试验方法3. Test method
3.1辐射方法:辐射剂量12、8.5 Gy,辐射率1 Gy/min。3.1 Radiation method: radiation dose 12, 8.5 Gy, radiation rate 1 Gy/min.
3.2动物处理:实验动物适应性饲喂3d后进行给药,空白对照组、辐照对照组给予0.2ml/d蒸馏水灌胃处理;阳性对照组、高剂量组、低剂量组分别给予适量浓度的实验药物0.2ml/d。给药2周后辐照处理,将各组辐照动物分为两半,其中一半做存活时间、体重测定实验,实验周期为30d;另一半饲喂3d后处死做其他参数测定。3.2 Animal treatment: The experimental animals were administered after adaptive feeding for 3 days. The blank control group and the irradiation control group were given 0.2ml/d distilled water orally; the positive control group, high-dose group, and low-dose group were given appropriate concentrations of Experimental drug 0.2ml/d. After 2 weeks of administration, the irradiated animals in each group were divided into two halves, one half of which was tested for survival time and body weight, and the experimental period was 30 days; the other half was fed for 3 days and then sacrificed for other parameters.
3.3参数测定3.3 Parameter Determination
测定种类:存活时间,体重,骨髓DNA含量,精子畸形率Measurement types: Survival time, body weight, bone marrow DNA content, sperm deformity rate
测定方法: 存活时间:在实验周期(30d)内记录实验小鼠存活时间状况,对不同处理小鼠存活时间进行显著性比较,分析巧克力样品对辐照小鼠存活时间的影响。Measurement method: Survival time: record the survival time of experimental mice within the experimental period (30 days), compare the survival time of mice with different treatments, and analyze the influence of chocolate samples on the survival time of irradiated mice.
体重:在实验周期(30d)内,每周测定小鼠体重,对同一时间点小鼠体重进行显著性比较,分析巧克力对辐照小鼠体重的影响。Body weight: During the experimental period (30 days), the body weight of the mice was measured every week, and the weight of the mice at the same time point was significantly compared to analyze the effect of chocolate on the body weight of the irradiated mice.
骨髓DNA含量测定:处死小鼠,取左侧股骨,除净肌肉组织,液氮保存(30d)。用5mmol/LCaCl21Oml将全部骨髓冲入离心管中,4℃冰箱放置30分钟,然后2500r/min离心15分钟,弃上清液。沉淀中加入5ml0.2mol/LHCl04,将沉淀物充分混匀,90℃水浴加热15分钟,冷却过滤,滤液用分光光度计在268nm处测定吸光度A值。DNA(ug)=40*50*ADetermination of bone marrow DNA content: the mice were sacrificed, the left femur was removed, and the muscle tissue was removed, and stored in liquid nitrogen (30 days). Wash all the bone marrow into a centrifuge tube with 5mmol/LCaCl21Oml, place in a refrigerator at 4°C for 30 minutes, then centrifuge at 2500r/min for 15 minutes, and discard the supernatant. Add 5ml of 0.2mol/L HCl04 to the precipitate, mix the precipitate thoroughly, heat in a water bath at 90°C for 15 minutes, cool and filter, and measure the absorbance A value of the filtrate at 268nm with a spectrophotometer. DNA(ug)=40*50*A
精子畸形率:小鼠处死后,取一侧附睾用眼科剪纵向剪开,置于装有0.2ml2%伊红溶液的小试管中,用吸管吹打30-40次,使精子从附睾中充分游离出来,静置染色3-5 min,摇匀,吸取精子悬液滴于清洁玻片上,推片,晾干,甲醇固定5 min,镜检计数,检测精子数目应大于500个。Sperm deformity rate: After the mice were sacrificed, one side of the epididymis was cut longitudinally with ophthalmic scissors, placed in a small test tube containing 0.2ml of 2% eosin solution, blown 30-40 times with a straw to free the sperm from the epididymis Come out, let stand for staining for 3-5 minutes, shake well, absorb the sperm suspension and drop it on a clean glass slide, push the slide, dry it, fix it with methanol for 5 minutes, and count under the microscope. The number of detected sperm should be more than 500.
3.4、数据处理:数据以mean±sd表示,组间数据显著性分析采用t检验。3.4. Data processing: The data are expressed as mean±sd, and the significance analysis of data between groups is performed by t test.
4、结果与结论4. Results and conclusions
4.1死亡时间见下表:4.1 See the table below for the time of death:
4.2 体重4.2 Weight
小鼠辐照前灌胃样品B,与其他样品相比,可显著抑制小鼠体重损失,保持小鼠生存状态。Compared with other samples, the sample B administered to the mice before irradiation can significantly inhibit the weight loss of the mice and maintain the survival status of the mice.
4.3 DNA含量测定4.3 DNA content determination
按照前期实验操作进行股骨骨髓DNA含量测定,测定结果进行方差分析,阳性对照药氨磷汀组、实施例2(B组)与其它各组在股骨骨髓DNA含量方面存在显著差异,其他各组差异不显著。The femoral bone marrow DNA content was measured according to the previous experimental operation, and the results were analyzed by variance analysis. There were significant differences in the femoral bone marrow DNA content between the positive control drug amifostine group, Example 2 (group B) and other groups, and the differences among other groups Not obvious.
4.4 精子畸形率4.4 Sperm deformity rate
结论:在小鼠照射前给予巧克力样品B高剂量组,可降低辐射诱发的精子畸型率,且给药剂量和给药时间与其呈正相关, 照射剂量与防护效应呈负相关。Conclusion: Giving the high-dose chocolate sample B group before irradiation can reduce the rate of sperm deformity induced by radiation, and the dose and time of administration are positively correlated with it, and the dose of irradiation is negatively correlated with the protective effect.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410369102.0A CN104126719B (en) | 2014-07-30 | 2014-07-30 | Preparation method for chocolate products with efficacy of radioresistance |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410369102.0A CN104126719B (en) | 2014-07-30 | 2014-07-30 | Preparation method for chocolate products with efficacy of radioresistance |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104126719A CN104126719A (en) | 2014-11-05 |
CN104126719B true CN104126719B (en) | 2017-01-18 |
Family
ID=51799770
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410369102.0A Active CN104126719B (en) | 2014-07-30 | 2014-07-30 | Preparation method for chocolate products with efficacy of radioresistance |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104126719B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107668298A (en) * | 2017-10-23 | 2018-02-09 | 无限极(中国)有限公司 | Chocolate 3d printing material and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130473A (en) * | 1995-12-15 | 1996-09-11 | 刘勇 | Fresh fruit filled chocolate |
CN1240588A (en) * | 1998-06-30 | 2000-01-12 | 肖树恩 | Health-care chocolate |
CN1440239A (en) * | 2000-06-30 | 2003-09-03 | 雀巢制品公司 | Candy products containing active ingredients |
CN102823705A (en) * | 2012-09-22 | 2012-12-19 | 徐州绿之野生物食品有限公司 | Preparation method of compound barbary wolfberry fruit and black garlic filled chocolate |
CN102835534A (en) * | 2012-09-22 | 2012-12-26 | 徐州绿之野生物食品有限公司 | Preparation method of compound ginseng and black ginkgo nut filled chocolate |
CN203040595U (en) * | 2012-11-30 | 2013-07-10 | 福建省好邻居食品工业有限公司 | Candy coated with chocolate |
CN103283910A (en) * | 2013-05-29 | 2013-09-11 | 马氏庄园南京食品有限公司 | Nourishment chocolate and preparation method thereof |
-
2014
- 2014-07-30 CN CN201410369102.0A patent/CN104126719B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1130473A (en) * | 1995-12-15 | 1996-09-11 | 刘勇 | Fresh fruit filled chocolate |
CN1240588A (en) * | 1998-06-30 | 2000-01-12 | 肖树恩 | Health-care chocolate |
CN1440239A (en) * | 2000-06-30 | 2003-09-03 | 雀巢制品公司 | Candy products containing active ingredients |
CN102823705A (en) * | 2012-09-22 | 2012-12-19 | 徐州绿之野生物食品有限公司 | Preparation method of compound barbary wolfberry fruit and black garlic filled chocolate |
CN102835534A (en) * | 2012-09-22 | 2012-12-26 | 徐州绿之野生物食品有限公司 | Preparation method of compound ginseng and black ginkgo nut filled chocolate |
CN203040595U (en) * | 2012-11-30 | 2013-07-10 | 福建省好邻居食品工业有限公司 | Candy coated with chocolate |
CN103283910A (en) * | 2013-05-29 | 2013-09-11 | 马氏庄园南京食品有限公司 | Nourishment chocolate and preparation method thereof |
Non-Patent Citations (2)
Title |
---|
人参冰淇林生产工艺优化;刘婷婷 等;《食品工业》;20140228;第35卷(第2期);第50-53页 * |
枸杞凝胶糖果的开发;陈玲 等;《农产品加工》;20131231(第6期);第33-34页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104126719A (en) | 2014-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104323342B (en) | A kind of nostoc nutrient powder, preparation method and application | |
CN103989165B (en) | A kind of thorn pears vitamin complex C sheet and its preparation method | |
CN103039658A (en) | Persimmon leaf and sweet tea leaf tea and preparation method thereof | |
CN103766738A (en) | Quinquagenarian formula health rice flour and preparation method thereof | |
CN110292090A (en) | A kind of blueberry lutein ester pressed candy and preparation method thereof | |
CN105707387A (en) | Lycopene composite tablet candy and preparation method thereof | |
CN103919143A (en) | Roxburgh rose collagen tablet and preparing method thereof | |
CN109288070A (en) | Health food and preparation method thereof containing selenoprotein | |
WO2019029115A1 (en) | Ginseng sugar for preserving health and tonifying kidney and preparation method therefor | |
CN106923130A (en) | Solid beverage, its preparation method and application containing west safflower | |
CN112273505A (en) | Lily health tea and preparation method thereof | |
CN106723068A (en) | A kind of sea cucumber lycopene selenium radioresistance capsule formula and its preparation technology | |
CN104126719B (en) | Preparation method for chocolate products with efficacy of radioresistance | |
CN109497458A (en) | A kind of giant salamander nutrient equilibrium health-preserving food and preparation method thereof | |
CN102007993B (en) | Sugarless theanine buccal tablets and preparation method thereof | |
CN105212040A (en) | A kind of composite nutrition powder containing blank corn and preparation method thereof | |
CN112841644A (en) | Ginseng walnut oligopeptide powder and preparation method thereof | |
CN105639282B (en) | Expand root health preservation powder and its preparation process in chrysanthemum mountain | |
CN106579410A (en) | Maca, ginseng and Lycium ruthenicum Murr. tablet and preparation method thereof | |
CN104605352A (en) | Maca and roxburgh rose nutrition composition for promoting body blood circulation and warmly invigorating kidney yang as well as preparation method and application thereof | |
CN103932014A (en) | Okra tea-fragrant health care rice and preparation method thereof | |
CN109007042A (en) | A kind of Chinese yam milk tablet and preparation method thereof | |
CN103444933B (en) | Tea bag for summer health-maintaining noon tea | |
CN105192580A (en) | Compound nutritive powder containing black peanuts and preparation method thereof | |
CN110214846A (en) | A kind of almond ringdove chrysanthemum health preserving tea and its preparation process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20141105 Assignee: Zhongnong Suoyuan (Shenzhen) Technology Co.,Ltd. Assignor: INSTITUTE OF SPECIAL ANIMAL AND PLANT SCIENCES OF CAAS Contract record no.: X2022980024405 Denomination of invention: A preparation method of chocolate products with anti radiation effect Granted publication date: 20170118 License type: Common License Record date: 20221202 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20141105 Assignee: Shenzhen Qianhai Fangxiang Creative Media Technology Co.,Ltd. Assignor: INSTITUTE OF SPECIAL ANIMAL AND PLANT SCIENCES OF CAAS Contract record no.: X2023980032167 Denomination of invention: A preparation method of chocolate products with anti-radiation effect Granted publication date: 20170118 License type: Common License Record date: 20230214 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20141105 Assignee: Jilin Haoxing Pharmaceutical Co.,Ltd. Assignor: INSTITUTE OF SPECIAL ANIMAL AND PLANT SCIENCES OF CAAS Contract record no.: X2025220000002 Denomination of invention: A method for preparing chocolate products with anti radiation effects Granted publication date: 20170118 License type: Common License Record date: 20250108 |
|
EE01 | Entry into force of recordation of patent licensing contract |